chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lacrimation increased, Oropharyngeal pain
Clinical narrative: Extreme Headache; chills; sore throat; water eyes; runny nose; tiredness; entire body aches; This is a spontaneous report from a contactable Nurse reporting for herself. A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 06Jan2021 14:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Nursing Home/Senior Living Facility. Medical history included prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme Headache, chills, sore throat, water eyes, runny nose, tiredness entire body aches on 07Jan2021. No treatment was received for the events. Since the vaccination, the patient has been tested for COVID-19, the patient underwent lab tests and procedures which included Covid-19 test/Nasal Swab: negative on 05Jan2021. The outcome of the events was unknown. Information about lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Extreme Headache; chills; sore throat; water eyes; runny nose; tiredness; entire body aches; This is a spontaneous report from a contactable Nurse reporting for herself. A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 06Jan2021 14:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Nursing Home/Senior Living Facility. Medical history included prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme Headache, chills, sore throat, water eyes, runny nose, tiredness entire body aches on 07Jan2021. No treatment was received for the events. Since the vaccination, the patient has been tested for COVID-19, the patient underwent lab tests and procedures which included Covid-19 test/Nasal Swab: negative on 05Jan2021. The outcome of the events was unknown. Information about lot/batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: arm soreness (minor) day after; Headache (minor) day of; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1618; expiry date: unknown) via an unspecified route of administration (left arm), on 07Jan2021 at 12:15, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient has no known allergies (NKA). Concomitant medications included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE]), naproxen sodium (NAPROSYN). It was unknown if the patient is pregnant at the of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 07Jan2021, at 13:00, the patient experienced headache (minor) day of. The patient experienced arm soreness (minor) day after (08Jan2021). The patient received naproxen as treatment for the events. Outcome of the events was recovered.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Headache, Nausea, Oropharyngeal pain
Clinical narrative: Fever; nausea; body aches; sore throat; cough; headache; This is a spontaneous report from a contactable nurse (reported for herself). A 23-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 142), intramuscular on 07Jan2021 at single dose at right arm for COVID-19 immunization. Medical history included known allergies: Penicillin, diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility type Vaccine was Doctor's office/urgent care. The patient experienced Fever, nausea, body aches, sore throat, cough, headache on 09Jan2021. No treatment received for the adverse events. The events were non-serious per the reporter. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever; nausea; body aches; sore throat; cough; headache; This is a spontaneous report from a contactable nurse (reported for herself). A 23-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 142), intramuscular on 07Jan2021 at single dose at right arm for COVID-19 immunization. Medical history included known allergies: Penicillin, diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility type Vaccine was Doctor's office/urgent care. The patient experienced Fever, nausea, body aches, sore throat, cough, headache on 09Jan2021. No treatment received for the adverse events. The events were non-serious per the reporter. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Throat irritation, Tongue pruritus, Vaccination site pruritus
Clinical narrative: Slight allergic reaction; itchiness immediately after the injection in the injection area; itchiness spread to parts of patients body like the back of her throat and tongue; itchiness spread to parts of the patients body like the back of their throat and tongue; itching to the area of the leg, the face, the head; This is a spontaneous report from a contactable consumer (patient). The 51-year-old patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) intramuscular (upper left arm), on 21Dec2020, at a single dose, for COVID-19 immunization/ prophylaxis. Relevant medical history included root canal. The patient has no concomitant medications. The patient previously took thimerosal (preservative) and experienced allergy. Patient knows the vaccine is preservative free. The patient received the first dose on 21Dec2020. She had a slight allergic reaction where she experienced itchiness immediately after the injection in the injection area (itching in the arm) and the itchiness spread to parts of her body like the back of her throat, tongue, area of the leg, the face, the head. She took three Benadryl as treatment for these events. The patient recovered completely that same evening (on 21Dec2020) before she went to bed around 10 or 11 that night after her third Benadryl. She was due to go back to get her second dose between 11Jan2021 and 13Jan2021, next week. She is concerned about getting the second dose since she had somewhat of a reaction with the first dose. She had to have a root canal and she was taking an antibiotic which she clarifies as a Z-pack, azithromycin. States her last antibiotic pill is due to be taken on Monday, 11Jan2021. She was asking if she can get the second dose. She is also concerned about how she may react to the 2nd dose of the vaccine while taking Azithromycin. They were informed at work that the 2nd dose of the vaccine should be administered between days 21 and 23 after the first one. Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Vision blurred
Clinical narrative: blurry vision; double vision; This is a spontaneous report from a non-contactable consumer. This consumer reported same events for two patients. This is first of two reports. A 7 decades old female patient received bnt162b2, via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blurry vision, double vision on an unspecified date. The reporter told that her elderly aunt and uncle (ages 60+ and 80+) received the Pfizer vaccine and experienced blurry vision and double vision. The outcome of events was resolving.   Information about Lot/Batch number is requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015734 same reporter/drug/AE with different patient
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore/pain injection site; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) intramuscular (left arm) on 17Dec2020 at 15:15, at a single dose, for COVID-19 immunization. Relevant medical history included hypertension (HTN), hypothyroid, and early pulmonary HTN. Concomitant medications were not reported. The patient previously received bactroban ointment and experienced allergies. Patient is a registered nurse working in a small, rural hospital. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On an unspecified date, the patient experienced sore/pain injection site. Outcome of the event was unknown. The patient has not been tested for COVID-19 since vaccination.
Sex: M
Vaccine: COVID19
Symptoms: Diplopia, Vision blurred
Clinical narrative: Blurry vision; double vision; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. A 9-decade-old (80+) male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported her elderly uncle experienced blurry vision and double vision on an unspecified date with outcome of recovering. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015730 same reporter/drug/AE with different patient.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Dizziness, Erythema, Hypoaesthesia
Clinical narrative: Left arm went total numb for over 72 hours; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Tighten in chest; Weakness; dizziness; Slept for over 24 hours; Nausea; vomiting; This is a spontaneous report from a contactable other Health Professional (HCP) (patient). A 46-year-old non-pregnant female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231), via an unspecified route of administration on 07Jan2021 14:30 at single dose in her left arm for covid-19 immunization. Medical history included dermatitis contact and asthma. The patient had allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730) at single dose in her left arm on 17Dec2020 14:30 for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient experienced feft arm went total numb for over 72 hours, red and swollen all the way up to the shoulder, tighten in chest, weakness and dizziness, slept for over 24 hours, nausea and vomiting on 08Jan2021 04:30. The events result in doctor or other healthcare professional office/clinic visit. The patient received prednisone 100 mg to treat these events. The outcome of the events was recovered in Jan2021.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Nausea, Peripheral swelling, Somnolence, Vomiting
Clinical narrative: Left arm went total numb for over 72 hours; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Tighten in chest; Weakness; dizziness; Slept for over 24 hours; Nausea; vomiting; This is a spontaneous report from a contactable other Health Professional (HCP) (patient). A 46-year-old non-pregnant female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231), via an unspecified route of administration on 07Jan2021 14:30 at single dose in her left arm for covid-19 immunization. Medical history included dermatitis contact and asthma. The patient had allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730) at single dose in her left arm on 17Dec2020 14:30 for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient experienced feft arm went total numb for over 72 hours, red and swollen all the way up to the shoulder, tighten in chest, weakness and dizziness, slept for over 24 hours, nausea and vomiting on 08Jan2021 04:30. The events result in doctor or other healthcare professional office/clinic visit. The patient received prednisone 100 mg to treat these events. The outcome of the events was recovered in Jan2021.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Lymph node pain, Nausea
Clinical narrative: Woke up with moderate fatigue, nausea, more severe arm pain than day before; Woke up with moderate fatigue, nausea, more severe arm pain than day before; Felt sweaty/chills, neck lymph glands tender; Felt sweaty/chills, neck lymph glands tender; neck lymph glands tender; Moderate arm pain that night; This is a spontaneous report from a contactable Nurse (patient). A 52-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL1284), intramuscularly on 04Jan2021 16:30 at single dose for COVID-19 immunization. Anatomical Located at Arm Right. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication which the patient received within 2 weeks of vaccination included colecalciferol (VITAMIN D), tocopherol (VITAMIN E), magnesium, ibuprofen, paracetamol (TYLENOL). The patient previously took amoxicillin and experienced allergy.  Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient experienced Moderate arm pain that night on 04Jan2021 19:00 and woke up with moderate fatigue, nausea, more severe arm pain than day before on 05Jan2021. At 23 hours post injection on 05Jan2021, the patient also felt sweaty/chills, neck lymph glands tender. All symptoms gone at 48 hrs post injection. The patient did not receive any treatment for the reported events. The outcome of the events was recovered in Jan2021. This case reported as non-serious.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Woke up with moderate fatigue, nausea, more severe arm pain than day before; Woke up with moderate fatigue, nausea, more severe arm pain than day before; Felt sweaty/chills, neck lymph glands tender; Felt sweaty/chills, neck lymph glands tender; neck lymph glands tender; Moderate arm pain that night; This is a spontaneous report from a contactable Nurse (patient). A 52-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL1284), intramuscularly on 04Jan2021 16:30 at single dose for COVID-19 immunization. Anatomical Located at Arm Right. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication which the patient received within 2 weeks of vaccination included colecalciferol (VITAMIN D), tocopherol (VITAMIN E), magnesium, ibuprofen, paracetamol (TYLENOL). The patient previously took amoxicillin and experienced allergy.  Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient experienced Moderate arm pain that night on 04Jan2021 19:00 and woke up with moderate fatigue, nausea, more severe arm pain than day before on 05Jan2021. At 23 hours post injection on 05Jan2021, the patient also felt sweaty/chills, neck lymph glands tender. All symptoms gone at 48 hrs post injection. The patient did not receive any treatment for the reported events. The outcome of the events was recovered in Jan2021. This case reported as non-serious.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Rash
Clinical narrative: When the patient got sick she got a rash that didn't itch all over her body; Chills; aching; fever; This is a spontaneous report from a contactable other health professional (patient). A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 06:45 AM at left arm, at single dose for covid-19 immunization. Medical history was none. Known allergies was no. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, unknown lot number and expiration date), via an unspecified route of administration on 18Dec2020 06:30 AM at left arm, at single dose for covid-19 immunization. The patient experienced chills, aching and fever 10 hours later at 08Jan2021 18:30. When the patient got sick she got a rash that didn't itch all over her body and it happened 24 hours after the vaccine, on 09Jan2021. No treatment was received for all events. The outcome of the events was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.  Information on lot number/batch number was requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Body temperature, Chills, Dizziness
Clinical narrative: Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; This is a spontaneous report from a contactable other-HCP (patient). A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1686), via an unspecified route of administration on 07Jan2021 13:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient is not pregnant. The facility type vaccine was hospital. Patient took the first dose of BNT162B2 on 17Dec2021 13:45 (lot number EK5730) at arm left for covid-19 immunization. The patient medical history was not reported. Concomitant medication included famotidine and birth control. The known allergies included Cefzil. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain on 08Jan2021 00:15 with outcome of recovering. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; This is a spontaneous report from a contactable other-HCP (patient). A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1686), via an unspecified route of administration on 07Jan2021 13:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient is not pregnant. The facility type vaccine was hospital. Patient took the first dose of BNT162B2 on 17Dec2021 13:45 (lot number EK5730) at arm left for covid-19 immunization. The patient medical history was not reported. Concomitant medication included famotidine and birth control. The known allergies included Cefzil. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain on 08Jan2021 00:15 with outcome of recovering. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Pain
Clinical narrative: Body, muscle and joint pain; Body, muscle and joint pain; Body, muscle and joint pain; Chills; Tired; This is a spontaneous report from a non-contactable healthcare professional. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (13:00) (Lot number: EK5730; Expiration date was not reported) and the second dose on 07Jan2021 (07:00) (Lot number: EL0140; Expiration date was not reported), both intramuscularly on the left arm at a single dose for COVID-19 immunization at the hospital. Medical history included sulfa allergy. Concomitant medications included colecalciferol (VITA D) and magnesium sulfate (MG). On 07Jan2021 (19:30), the patient had body, muscle and joint pain; chills; and tired. The patient did not receive any treatment for the events. The patient's COVID test was negative on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination. The outcome of the events, 'body, muscle and joint pain', 'chills' and 'tired', was recovering.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Body, muscle and joint pain; Body, muscle and joint pain; Body, muscle and joint pain; Chills; Tired; This is a spontaneous report from a non-contactable healthcare professional. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (13:00) (Lot number: EK5730; Expiration date was not reported) and the second dose on 07Jan2021 (07:00) (Lot number: EL0140; Expiration date was not reported), both intramuscularly on the left arm at a single dose for COVID-19 immunization at the hospital. Medical history included sulfa allergy. Concomitant medications included colecalciferol (VITA D) and magnesium sulfate (MG). On 07Jan2021 (19:30), the patient had body, muscle and joint pain; chills; and tired. The patient did not receive any treatment for the events. The patient's COVID test was negative on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination. The outcome of the events, 'body, muscle and joint pain', 'chills' and 'tired', was recovering.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen and painful lymph nodes under arms; Swollen and painful lymph nodes under arms; This is a spontaneous report from a contactable nurse (patient herself). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248; expiry date: unknown) via intramuscular route in the left arm, on 07Jan2021 at 14:00, at a single dose, for COVID-19 immunization. Relevant medical history included anxiety, depression, hypothyroid, and hypertension. The patient has no known allergies. Concomitant medications included levothyroxine, escitalopram, paracetamol (TYLENOL), ibuprofen, and marijuana. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1685) intramuscular route in the left arm, on 18Dec2020 at 13:00, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 08Jan2021, at 21:00, the patient experienced swollen and painful lymph nodes under arms. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: muscle aches; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Ek9231) solution for injection in the left arm on 07Jan2021 at 18:15 (at the age of 37-years-old) as a single dose for COVID-19 vaccination. Medical history was not reported. Concomitant medication included unspecified vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 08Jan2021 at 20:00, the patient experienced muscle aches and headache. No treatment was provided for the events muscle aches and headache. The outcome of the events muscle aches and headache was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia, Tremor
Clinical narrative: Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; This is a spontaneous report from a contactable other health care professional (patient).  A 31-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration (left arm) second dose on 07Jan2021 09:30 at single dose for covid-19 immunisation. The patient's medical history included known allergies: Sulfa drugs and known allergies: latex sensitivity. The patient's concomitant medication included spironolactone, bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), and multi vitamin. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), for covid-19 immunisation first dose on 17Dec2020, Vaccine location Left arm, lot number EH9899. On 07Jan2021 10:00 PM, the patient experienced Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours. The patient did not received treatment for the events. The outcome of the events was recovered in Jan2021. Facility where the most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not tested positive for covid post vaccination.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; This is a spontaneous report from a contactable other health care professional (patient).  A 31-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration (left arm) second dose on 07Jan2021 09:30 at single dose for covid-19 immunisation. The patient's medical history included known allergies: Sulfa drugs and known allergies: latex sensitivity. The patient's concomitant medication included spironolactone, bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), and multi vitamin. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), for covid-19 immunisation first dose on 17Dec2020, Vaccine location Left arm, lot number EH9899. On 07Jan2021 10:00 PM, the patient experienced Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours. The patient did not received treatment for the events. The outcome of the events was recovered in Jan2021. Facility where the most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not tested positive for covid post vaccination.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Malaise, Pain, Pyrexia
Clinical narrative: malaise; headache; low grade fever; dizziness; overall body aches; This is a spontaneous report from a contactable other healthcare professional (patient). A 63-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided as unable to locate or read the details), intramuscularly on 08Jan2021 at 10:30 AM on Left arm at single dose for COVID-19 immunization in hospital. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided) intramuscularly on 18Dec2020 at 10:15 AM on Left arm at single dose for COVID-19 immunization at age of 63-year-old. Prior to vaccination, patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced malaise, headache, low grade fever, dizziness, overall body aches on 08Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  Information on the Lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, Vaccination site discolouration
Clinical narrative: Palm-sized discoloration around injection site; arm was very sore; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 12:00 in left arm at single dose for COVID-19 immunization. Medical history included hay fever, asthma, various allergies and high blood pressure from an unknown date and unknown if ongoing. Concomitant medication included progesterone, metformin, atorvastatin and metoprolol. On 05Jan202115:00, the patient experienced palm-sized discoloration around injection site and arm was very sore for two days. No treatment was given to the patient for the events. The patient recovered from the events on unspecified date. The patient underwent laboratory test which includes nasal swab: negative on 07Jan2021. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Malaise, Myalgia, Pyrexia
Clinical narrative: After my second vaccine, I have developed a dry cough/I have had the cough for 24 hours so far; at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); This is a spontaneous report from a contactable physician (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via Intramuscular at single dose in the right arm, first dose (lot: EK5730) on 17Dec2020 11:30 am, second dose (lot EL0142) on 07Jan2021 18:00, both for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. After his second vaccine, on 08Jan2021, he has developed a dry cough at the same time he experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally). He has no known exposure to Covid 19 in the last few weeks. He has had the cough for 24 hours so far. The patient did not receive any treatment. Outcome of events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Sinus headache, Tinnitus, Vertigo
Clinical narrative: Funky lightheadedness; Normal tinnitus got louder and oscillating up and down; Sinus headache; Vertigo; This is a spontaneous report from a contactable pharmacist.  A 50-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), intramuscular at arm right on 17Dec2020 13:30 at single dose for COVID-19 immunization at a Workplace clinic. The patient's medical history was reported as none. No known drug allergies. Concomitant medication (received within 2 weeks of vaccination) included ergocalciferol (VIT D). The patient was not diagnosed with COVID-19 prior to vaccination. It was reported that while getting first dose, patient experienced instant "funky lightheadedness, vertigo. Normal tinnitus got louder and oscillating up and down. Next day after first dose (18Dec2020), patient had sinus headache and vertigo, took meclizine and went back to bed. Felt fine when she woke up. The outcome of the events sinus headache and vertigo was recovered on an unspecified date, for the rest of events was unknown. The reporter consider the evens as non-serious.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Influenza like illness, Limb discomfort
Clinical narrative: flu-like symptoms; dizziness; heavy feet; This is a spontaneous report from a contactable pharmacist reporting for herself. A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek9231), via an unspecified route of administration on 07Jan2021 13:45 in left arm at single dose for COVID-19 immunization. Medical history included allergies to cherries and hazelnuts amd Hashimoto's thyroiditis from an unknown date and unknown if ongoing; h/o possible GBS (Guillain-Barre syndrome) from an unknown date and unknown if ongoing post influenza vaccine in 2016. Concomitant medication included fish oil, minerals nos, quercetin, thioctic acid, vitamins (EMERGEN-C) and multivitamins. On 08Jan2021, the patient experienced flu-like symptoms and bouts of dizziness, and a feeling of "heavy feet" 24 hours post administration of BNT162B2. No treatment was given to the patient for the events. The outcome of the events was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine headache; This is a spontaneous report from a contactable nurse reporting for herself. A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular from 20Dec2020 11:00 in left arm to 20Dec2020 11:00 at single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medication included cetirizine hydrochloride (ZYRTEC). On 20Dec2020 17:00, the patient experienced migraine headache approximately 6hrs after injection. The patient recovered on unspecified date. No treatment was given to the patient for the event. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The event was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen painful lymph nodes left armpit; Swollen painful lymph nodes left armpit; This is a spontaneous report from a non-contactable nurse reporting for herself. A 41-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 08:00 in left arm at single dose for COVID-19 immunization. Medical history included sulfa allergy from an unknown date and unknown if ongoing. Concomitant medication included buspirone hydrochloride (BUSPAR), lamotrigine (SUBVENITE) and quetiapine fumarate (SEROQUEL). The patient previously took amoxicillin and experienced allergies and received first dose of BNT162B2. The patient experienced swollen painful lymph nodes left armpit on an unspecified date. The outcome of the events was unknown. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Movement disorder, Neck pain, Vaccination site pain
Clinical narrative: trouble lifting things like my tea kettle; lot of pain in right elbow; bad neck and shoulder pain; bad neck and shoulder pain; sore right arm similar to after a tetanus shot; This is a spontaneous report from a non-contactable nurse (patient).  A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot number: EL1284, intramuscular on right arm from 05Jan2021 09:45 to 05Jan2021 09:45 as single dose (first dose) for COVID-19 immunisation.  Medical history included none.  The patient's concomitant medications were not reported. On 05Jan2021 at 03:00pm, the patient experienced sore right arm similar to after a tetanus shot. On 06Jan2021, the pain in upper arm gone but by afternoon but the patient got bad neck and shoulder pain on right side that she treated with heat and Advil. On 07Jan201, neck pain still present and by late afternoon, the patient got a lot of pain in right elbow. On 08Jan2021, the patient still have the neck to shoulder pain in addition to the right elbow pain. It feels like she sprained her elbow and was having trouble lifting things like my tea kettle. The outcome of the event sore right arm/pain in upper arm was recovered on 06Jan2021; having trouble lifting things like my tea kettle was unknown; while the other events were not recovered. Treatment has been given for the event bad neck and shoulder pain. Since the vaccination, the patient has not been tested for COVID-19.   No follow up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Rash around entire neck; Swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) solution for injection, intramuscular on left arm on 06Jan2021 12:00 at a single dose for Covid-19 immunization. Medical history included scoliosis, sport-induced asthma, and seasonal allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), ibuprofen (IBUPROFEN), and meclozine hydrochloride (BONINE). The patient experienced rash around entire neck and swollen lymph nodes, both on 09Jan2021 06:00. No treatment received. The events were reported as non-serious. Patient was not diagnosed with Covid-19 prior to vaccination. Patient has not tested for Covid-19 since the vaccination. Outcome of the event was not recovered.    No follow-up activities are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site discomfort
Clinical narrative: I woke about 3 am and had paresthesia of my fingers on my right hand. Thumb, index, middle and ring fingers. I Thought that I had slept in my hand wrong.; The discomfort at injection site woke me again last night and had the same feeling. It has remained after waking this morning; This is a spontaneous report from a contactable physician (patient). A 50-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK 7530) solution for injection, via an unspecified route of administration on right arm on 08Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history was reported as none. The patient has no allergies to food, medications, or other products. The patient was not pregnant. Patient had the first dose of BNT162B2 on 18Dec2020 (lot number: EK 7530). Concomitant medications included multivitamins [vitamins nos] (MULTIVITAMINS [VITAMINS NOS]), ascorbic acid, biotin, folic acid, iodine, pantothenic acid, pyridoxine hydrochloride, retinol, vitamin b12 nos, vitamin d nos, vitamin e nos, zinc (CENTRUM MULTIGUMMIES), and melatonin at 1.5 mg, daily. The patient reported that on 09Jan2021, she woke about 3 am and had paresthesia of her fingers on her right hand, thumb, index, middle and ring fingers. She thought that she had slept in her hand wrong. The discomfort at injection site woke her again last night (09Jan2021) and had the same feeling. It has remained after waking this morning. No treatment was given. The patient was not diagnosed with Covid-19 prior to vaccination and has not been tested for Covid-19 since vaccination. Outcome of the events was not recovered.  No follow-up activities are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives after first shot; This is a spontaneous report from a non-contactable healthcare professional (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, via an unspecified route of administration, the first dose on 15Dec2020 (lot number: EH9899) at a single dose, then the second dose on 08Jan2021 (lot number: EK9231) at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient experienced hives after first shot on 15Dec2020. No treatment received. Outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.